Key statistics
As of last trade Anika Therapeutics Inc (ANIK:NSQ) traded at 25.52, -12.35% below its 52-week high of 29.12, set on Jul 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.27 |
---|---|
High | 25.65 |
Low | 25.27 |
Bid | 25.46 |
Offer | 25.57 |
Previous close | 25.25 |
Average volume | 56.82k |
---|---|
Shares outstanding | 14.80m |
Free float | 14.30m |
P/E (TTM) | -- |
Market cap | 373.62m USD |
EPS (TTM) | -5.06 USD |
Data delayed at least 15 minutes, as of Oct 11 2024 19:03 BST.
More ▼
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Anika to Participate in the Sidoti Virtual Investor Conference
- Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024
- Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
- Anika Enters into Cooperation Agreement with Caligan Partners
- Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
- Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
- Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
- Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
More ▼